Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Pragmatic EE-PRS Trial for CVD Prevention
NCT06820086Phase 4Active, not recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in cardiovascular disease (CVD). Started Mar 2025; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT06820086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06820086.